VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NXQuanex Building Products Corporation
$17.96$825M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksNXFinancials

Quanex Building Products Corporation (NX) Financials

30Y historyFree accessUpdated daily

Revenue growth has decelerated to 2.2% in 2026Q2, while gross margins have contracted significantly from a 2025 peak of 29.0% to 20.1% as integration costs weigh on profitability.

NX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMOct'25Oct'24Oct'23Oct'22Oct'21Oct'20Oct'19Oct'18Oct'17Oct'16Oct'15Oct'14Oct'13Oct'12Oct'11Oct'10Oct'09Oct'08Oct'07Oct'06Oct'05Oct'04Oct'03Oct'02Oct'01Oct'00Oct'99Oct'98Oct'97Oct'96
Sales/Revenue1.86B1.84B1.28B1.13B1.22B1.07B851.57M893.84M889.78M866.55M928.18M645.53M595.38M952.64M828.98M848.29M798.31M585.01M868.93M2.05B2.03B1.97B1.46B1.03B994.39M924.35M934.2M810.09M797.49M746.09M895.71M
Revenue Growth %14.25%43.81%13.03%-7.44%13.93%25.9%-4.73%0.46%2.68%-6.64%43.79%8.42%-37.5%14.92%-2.28%6.26%36.46%-32.67%-57.59%0.81%3.23%34.84%41.61%3.7%7.58%-1.05%15.32%1.58%6.89%-16.7%0.51%
Cost of Goods Sold1.41B1.34B972.24M853.06M953M831.54M658.75M694.42M697.02M672.49M710.64M499.1M464.58M419.73M355.67M712.09M660.85M489.33M717.38M767.14M829.71M1.51B1.25B867.78M812.95M769.33M730.86M710.04M647.18M609.99M772.37M
COGS % of Revenue-72.83%76.08%75.45%78.02%77.56%77.36%77.69%78.34%77.6%76.56%77.32%78.03%44.06%42.9%83.94%82.78%83.64%82.56%37.44%40.82%76.84%85.3%84.15%81.75%83.23%78.23%87.65%81.15%81.76%86.23%
Gross Profit442.95M499.23M305.62M277.52M268.5M240.61M192.82M199.42M192.76M194.07M217.54M146.43M130.8M135.13M122.91M136.2M137.47M95.68M151.56M196.84M214.06M456.03M214.63M163.43M181.44M155.03M75.47M124.86M150.31M136.1M123.34M
Gross Margin %23.86%27.17%23.92%24.55%21.98%22.44%22.64%22.31%21.66%22.4%23.44%22.68%21.97%14.19%14.83%16.06%17.22%16.36%17.44%9.61%10.53%23.16%14.7%15.85%18.25%16.77%8.08%15.41%18.85%18.24%13.77%
Gross Profit Growth %-63.35%10.13%3.36%11.59%24.78%-3.31%3.45%-0.67%-10.79%48.56%11.95%-3.21%9.95%-9.76%-0.92%43.67%-36.87%-23%-8.05%-53.06%112.47%31.33%-9.92%17.04%105.4%-39.55%-16.93%10.44%10.35%9.03%
Operating Expenses649.28M693.18M250.8M166.82M157.22M158.74M137.56M225.85M157.07M160.13M181.19M121.76M116.52M153.96M131.77M119.72M100.17M274.78M130.58M108.67M109.3M163.25M-647.49M-54.26M-60.81M-66.62M053.1M148.05M81.1M56.8M
OpEx % of Revenue-37.72%19.63%14.76%12.87%14.81%16.15%25.27%17.65%18.48%19.52%18.86%19.57%16.16%15.9%14.11%12.55%46.97%15.03%5.3%5.38%8.29%-44.34%-5.26%-6.12%-7.21%-6.56%18.56%10.87%6.34%
Selling, General & Admin286.14M277.26M190.47M123.96M117.11M115.97M89.71M101.29M103.53M97.98M114.91M86.54M82.15M109.33M111.58M83.99M71.95M60.47M95.5M97.99M92.7M97.85M65.62M53.57M54.41M54.2M53.55M53.1M47.71M43.8M56.8M
SG&A % of Revenue-15.09%14.91%10.96%9.59%10.82%10.53%11.33%11.64%11.31%12.38%13.41%13.8%11.48%13.46%9.9%9.01%10.34%10.99%4.78%4.56%4.97%4.49%5.2%5.47%5.86%5.73%6.56%5.98%5.87%6.34%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses2M415.92M60.33M42.87M40.11M42.77M47.85M124.56M53.31M62.05M66.28M35.22M34.37M54.99M30.89M35.73M28.21M215.01M35.07M37.99M37M65.4M-713.1M-107.83M-115.22M-120.82M-53.55M0100.33M37.3M0
Operating Income-206.33M-193.95M54.83M110.7M111.28M81.87M55.27M48.66M36.38M34.37M36.35M24.68M14.28M-17.73M-24.95M16.48M37.3M-180.08M20.98M4.05M251.39M292.77M99.41M63.8M83.3M57.32M-3.96M71.76M2.26M55.01M66.54M
Operating Margin %-11.11%-10.55%4.29%9.79%9.11%7.64%6.49%5.44%4.09%3.97%3.92%3.82%2.4%-1.86%-3.01%1.94%4.67%-30.78%2.41%0.2%12.37%14.87%6.81%6.19%8.38%6.2%-0.42%8.86%0.28%7.37%7.43%
Operating Income Growth %--453.76%-50.47%-0.52%35.92%48.14%13.58%33.77%5.84%-5.46%47.33%72.84%180.52%28.95%-251.43%-55.82%120.71%-958.31%417.54%-98.39%-14.13%194.51%55.83%-23.42%45.33%1546.64%-105.52%3069.48%-95.88%-17.33%0.09%
EBITDA-97.92M-90.51M115.15M153.57M151.39M124.6M102.49M98.25M88.2M91.86M89.5M59.9M51.19M42.77M12.71M50.48M65.58M35.27M56.09M81.36M323.05M358.76M150.01M110.21M127.29M101.23M44.48M117.64M44.66M92.87M104.96M
EBITDA Margin %-5.27%-4.93%9.01%13.58%12.39%11.62%12.04%10.99%9.91%10.6%9.64%9.28%8.6%4.49%1.53%5.95%8.21%6.03%6.46%3.97%15.89%18.22%10.27%10.69%12.8%10.95%4.76%14.52%5.6%12.45%11.72%
EBITDA Growth %-168.75%-178.6%-25.01%1.44%21.5%21.57%4.32%11.39%-3.99%2.64%49.43%17.01%19.66%236.47%-74.81%-23.03%85.96%-37.13%-31.06%-74.81%-9.95%139.15%36.12%-13.42%25.75%127.56%-62.19%163.39%-51.91%-11.51%6.11%
D&A (Non-Cash Add-back)108.41M103.44M60.33M42.87M40.11M42.73M47.23M49.59M51.82M57.49M53.15M35.22M36.91M60.5M37.67M34M28.28M215.35M35.11M77.31M71.66M65.99M50.6M46.41M43.99M43.91M48.45M45.88M42.4M37.87M38.42M
EBIT-194.17M-186.78M62.67M105.18M112.32M82.62M55.55M-26.31M36.85M35.1M30.87M24.14M14.37M-18.65M-8.64M15.96M39.94M-178.69M20.98M88.17M255.63M292.77M624.06M878.41M831.57M51.27M75.47M71.76M60.76M55.01M66.54M
Net Interest Income-51.09M-53.72M-18.9M-7.89M-2.54M-2.52M-5.22M-9.58M-11.03M-9.51M-36.39M-927K-443K-558K-225K-138K-440K-452K00-1.02M0000000000
Interest Income1M2.09M1.69M248K19K5K28K63K69K86K106K64K119K63K206K311K000000000000000
Interest Expense52.09M55.81M20.59M8.14M2.56M2.53M5.25M9.64M11.1M9.6M36.5M991K562K621K431K449K440K453K00708K31.22M8.9M007.61M7.28M8M105.51M010.26M
Other Income/Expense-39.93M-48.64M-12.74M-13.65M-1.52M-1.78M-4.96M-9.53M-12.41M-8.87M-41.98M-1.52M-470K-472K-16.32M-963K2.21M-46K4.71M-208K-578K-9.15M49.27M2.03M-1.69M-6.22M-90.88M-11.41M-8.23M-12.37M-9.83M
Pretax Income-246.26M-242.59M42.08M97.05M109.76M80.09M50.3M-35.95M25.45M25.5M-5.62M23.15M13.81M-18.2M-25.18M15.52M39.5M-180.13M25.69M207.06M250.82M283.63M93.64M65.82M81.61M45.05M-15.41M60.35M-5.96M42.64M56.71M
Pretax Margin %-13.26%-13.2%3.29%8.58%8.99%7.47%5.91%-4.02%2.86%2.94%-0.61%3.59%2.32%-1.91%-3.04%1.83%4.95%-30.79%2.96%10.11%12.34%14.4%6.41%6.38%8.21%4.87%-1.65%7.45%-0.75%5.72%6.33%
Income Tax10.89M8.21M9.02M14.54M21.43M23.11M11.8M10.78M-875K6.82M-3.77M7.54M5.47M-6.5M-8.65M6.44M15.3M-43.04M9.79M72.44M90.5M106.39M36.05M22.94M26.13M16.23M-5.38M21.05M-2.09M14.93M23.82M
Effective Tax Rate %-4.42%-3.39%21.44%14.99%19.52%28.86%23.47%-29.97%-3.44%26.74%66.95%32.56%39.61%35.7%34.35%41.49%38.73%23.89%38.09%34.99%36.08%37.51%38.49%34.84%32.02%36.02%34.94%34.88%34.99%35%42%
Net Income-257.16M-250.81M33.06M82.5M88.34M56.98M38.5M-46.73M26.33M18.68M-1.86M16.09M29.23M-11.7M-16.53M9.07M23.1M-137.09M21.58M134.62M160.18M155.16M54.47M42.89M55.48M29.19M-9.66M39.72M9.17M69.18M30.37M
Net Margin %-13.85%-13.65%2.59%7.3%7.23%5.31%4.52%-5.23%2.96%2.16%-0.2%2.49%4.91%-1.23%-1.99%1.07%2.89%-23.43%2.48%6.57%7.88%7.88%3.73%4.16%5.58%3.16%-1.03%4.9%1.15%9.27%3.39%
Net Income Growth %-1607.1%-858.66%-59.93%-6.61%55.03%48.02%182.38%-277.49%40.92%1105%-111.55%-44.95%349.8%29.22%-282.37%-60.75%116.85%-735.3%-83.97%-15.96%3.24%184.87%27%-22.7%90.05%402.06%-124.34%333.16%-86.75%127.82%-4.62%
Net Income (Continuing)-257.16M-250.81M33.06M82.5M88.34M56.98M38.5M-46.73M26.55M18.68M-1.86M15.61M8.34M-11.7M-16.53M9.08M24.2M-137.09M15.9M134.62M160.31M177.23M57.43M43.65M53.28M25.57M39.02M39.3M-3.88M27.72M32.89M
Discontinued Operations00000000000479K0000005.67M000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)-5.63-5.430.902.502.661.701.17-1.420.750.54-0.050.470.78-0.32-0.450.240.61-3.670.563.414.083.950.640.510.660.35-0.311.150.291.950.91
EPS Growth %-1038.41%-703.33%-64%-6.02%56.47%45.3%182.39%-289.33%38.89%1083.61%-111.68%-39.74%343.75%28.89%-287.5%-60.66%116.62%-755.36%-83.58%-16.42%3.29%517.19%25.49%-22.73%88.57%212.9%-126.96%296.55%-85.13%114.29%0%
EPS (Basic)--5.430.912.512.671.721.18-1.420.760.55-0.050.470.79-0.32-0.450.240.62-3.670.583.644.274.110.640.510.660.35-0.311.240.292.190.99
Diluted Shares Outstanding45.66M46.17M36.65M33.03M33.2M33.49M32.82M32.96M35.02M34.84M33.88M34.5M37.68M36.86M36.62M37.54M37.67M37.34M38.53M39.51M39.71M39.81M37.5M36.9M36.21M34.7M31.44M32.03M31.84M37.63M37.32M
Basic Shares Outstanding45.48M46.17M36.42M32.82M33.05M33.19M32.69M32.96M34.7M34.23M33.88M33.99M37.13M36.42M36.45M37.01M37.22M37.34M37.27M36.98M37.48M37.77M36.9M36.4M32.18M30.14M31.11M32.03M31.84M31.57M30.73M
Dividend Payout Ratio--36.21%12.9%12%18.92%27.36%-26.66%29.52%-34.27%20.5%--65.95%22.84%-10.46%15.43%11.46%9.21%21.17%25.33%17.37%29.53%-22.97%98.8%12.17%26.72%

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Acquisition integration and leverage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Revenue Volatility Following Tyman Acquisition

As indicated by the quarterly income statement data, Quanex experienced a significant revenue jump in 2025, with growth rates peaking at 76.7% in 2025Q3, though recent figures suggest a deceleration to 2.2% in 2026Q2 as the company navigates the post-acquisition integration of Tyman plc.

The sharp revenue expansion observed in mid-2025 reflects the inorganic contribution of the Tyman acquisition rather than organic demand strength. Investors should monitor whether the company can sustain these higher revenue levels as the housing market faces headwinds from elevated interest rates and stagnant new construction starts.

Margin Compression Amid Integration Pressures

Based on reported financial statements, gross margins have fluctuated significantly, dropping to 20.1% in 2026Q2 from a 2025 peak of 29.0%, suggesting that the company is struggling to maintain pricing power while absorbing the cost structures of its newly acquired international business units.

The compression in gross margins appears to be driven by a combination of raw material volatility and the integration of lower-margin product lines. This trend warrants further investigation into whether the current margin profile represents a structural decline or a temporary impact from purchase price accounting adjustments.

Operating Leverage Obscured by Expenses

According to the provided income statement, operating income has been highly erratic, swinging from a massive loss of $270.8M in 2025Q3 to a modest profit of $18.7M in 2026Q2, which suggests that operating leverage is currently masked by significant non-recurring transaction and integration-related costs.

The inability to consistently scale operating income relative to gross profit indicates that the company's overhead remains bloated following its recent expansion. Until these integration expenses subside, it remains difficult to determine the true underlying efficiency of the combined entity's SG&A structure.

Earnings Quality Impacted by Volatility

As reported in recent filings, net income has exhibited extreme volatility, including a $276.0M loss in 2025Q3, which highlights that reported EPS is currently an unreliable indicator of the company's core operational performance due to the heavy influence of non-operating acquisition-related charges.

The wide variance in quarterly net income suggests that investors should focus on adjusted metrics that strip out the noise of the Tyman integration. The persistent, albeit small, stock-based compensation expenses further complicate the assessment of true shareholder value creation during this transition period.

Structural Risks to Margin Recovery

Based on the provided data, the persistent weakness in operating margins, which reached -10.55% in recent periods, suggests that the company may face long-term challenges in achieving the synergies promised by management, potentially leading to a prolonged period of earnings underperformance relative to historical benchmarks.

Short-sellers may focus on the company's inability to stabilize profitability despite the increased scale provided by the Tyman acquisition. If the company fails to demonstrate a clear path to margin expansion in the coming quarters, the market may continue to discount the stock as a value trap.

NX — Frequently Asked Questions

Quick answers to the most common questions about buying NX stock.

What was Quanex Building Products Corporation's (NX) revenue in 2025?

For fiscal year 2025, Quanex Building Products Corporation (NX) reported total revenue of $1.84B. This represents a 105.2% increase compared to $895.7M in 1996.

Is Quanex Building Products Corporation (NX) profitable?

Quanex Building Products Corporation (NX) reported a net loss of $250.8M for the fiscal year ending 2025.

What is Quanex Building Products Corporation's operating profit margin?

Quanex Building Products Corporation (NX) reported an operating income of $-194.0M, resulting in an operating profit margin of -10.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Quanex Building Products Corporation's gross profit and gross margin?

Quanex Building Products Corporation (NX) generated $499.2M in gross profit for the year, representing a gross profit margin of 27.2%. This demonstrates the company's core pricing power and production efficiency.